Difference between revisions of "Software:OWise"

From HandWiki
Jump to: navigation, search
(import)
 
m (Jworkorg moved page Software:OWise (mobile and web app) to Software:OWise without leaving a redirect)
(No difference)

Revision as of 09:42, 2 August 2020

OWise
Original author(s)Anne Bruinvels
Developer(s)Px HealthCare
Initial release2013
Operating systemiOS & Android
Available in2 languages
List of languages
Dutch, English
TypeCancer support and symptom-tracking app
Websitewww.owise.uk

OWise is a mobile app and website developed for cancer patients by Px HealthCare, the Patient Experience company. Through OWise, Px offers cancer patients a smart digital platform where they can gain insight into their cancer diagnosis whilst also providing tools to feel more in control [1].

OWise is recommended across NHS England [2], and in 2017, IQVIA listed it in the top 25 of all 318,000 health apps [3].

OWise was initially developed for breast cancer patients and is currently expanding to other cancer types, with the next OWise app being developed for prostate cancer [4] .

History

OWise was created by Dr. Anne Bruinvels, Px HealthCare's CEO and the former Executive Director at the European Personalised Medicine Association (EPEMED)[5][6].

OWise was first launched in the Netherlands in 2013 and then brought to the UK in 2016 through the NHS Innovation Accelerator (NIA) programme[7][8][9].

Mobile App and Website

OWise aims to empower patients throughout cancer by providing the user with  personalised medical information, and a tailored list of suggested questions, to help them improve discussions with their clinicians. Self-management features include the ability to enter appointments and treatment plan, and to privately store photos and audio recordings[1]. Additionally, actively monitoring side effects with OWise can uncover insights for both patients and clinicians that could potentially improve patients’ outcomes.

OWise has been integrated successfully into the hospital’s electronic record system of NHS Lothian[10], enabling care teams to monitor patients effectively and avoid unnecessary, costly emergency visits. This integration, whereby remote-patient monitoring results in real-time Patient Reported Outcome (PRO) data accessible to the care team, can be critical in scenarios such as the current COVID-19 pandemic.

Clinical Research and Awards

OWise was the first cancer medical app to be used as a NICE exemplar [11], it is NHS Digital approved[2] and CE marked (Class I Medical Device)[12].

It is currently undergoing a randomised clinical trial at the Royal Marsden NHS Trust [13] . Additionally, it has undergone substantial peer-reviews [14][15][16].

In 2018, OWise was one of the projects selected to win the finals and progress to phase two of the Cancer Innovation Challenge[17][18].

Px HealthCare was awarded one of the top NESTA Healthier Lives Data Fund prizes to develop OWise for prostate cancer further and to scale across Scotland[19]

External Links

OWise breast cancer app at Google Playstore

OWise breast cancer app at Apple Appstore

OWise breast cancer app at NHS Apps LibraryTemplate:AFC submission/draft Script error: No such module "AFC submission catcheck".




References

  1. 1.0 1.1 "OWise UK". https://owise.net/uk/. 
  2. 2.0 2.1 "OWise breast cancer app - NHS" (in en). https://www.nhs.uk/apps-library/owise-breast-cancer/. 
  3. IQVIA (2017). The Growing Value Of Digital Health. https://www.iqvia.com/insights/the-iqvia-institute/reports/the-growing-value-of-digital-health. 
  4. "OWise - Increasing opportunities to access health data and knowledge". 2019. https://www.nesta.org.uk/case-studies/owise/. 
  5. "Our team - OWise UK". https://owise.net/uk/our-team/. 
  6. "Anne Bruinvels joins EPEMED as executive director". Manufacturing Chemist. July 6, 2010. https://www.manufacturingchemist.com/jobs/article_page/Anne_Bruinvels_joins_EPEMED_as_executive_director/55424. 
  7. "OWise: the innovative breast cancer app offering a helping hand to patients throughout their treatment". The AHSN Network. February 19, 2016. https://www.ahsnnetwork.com/owise-innovative-breast-cancer-app-offering-helping-hand-patients-throughout-treatment. 
  8. "Anne Bruinvels". https://nhsaccelerator.com/fellows-and-mentors/anne-bruinvels/. 
  9. "OWise breast cancer app proven to be effective tool in cancer treatment process". NHS Innovation Accelerator. June 23, 2016. https://nhsaccelerator.com/owise-breast-cancer-app-proven-to-be-effective-tool-in-cancer-treatment-process/. 
  10. Russell, Greg (February 20, 2020). "NHS Lothian trials groundbreaking OWise cancer patient app". The National. https://www.thenational.scot/news/18250395.nhs-lothian-trials-groundbreaking-owise-cancer-patient-app/. 
  11. Craig, Joyce; Shore, Judith; Russell, Joel (February 25, 2019). "Examples of Effectiveness and Economic Digital Health Case Studies". National Institute for Health and Care Excellence. https://www.nice.org.uk/Media/Default/About/what-we-do/our-programmes/evidence-standards-framework/evidence-case-studies.pdf. 
  12. "CE-marked: Class I Medical Device". https://owise.net/uk/ce-marked-class-i-medical-device/. 
  13. Lidington, Emma; McGrath, Sophie E.; Noble, Jillian; Stanway, Susannah; Lucas, Amanda; Mohammed, Kabir; van der Graaf, Winette; Husson, Olga (2020-01-15). "Evaluating a digital tool for supporting breast cancer patients: a randomized controlled trial protocol (ADAPT)". Trials 21 (1): 86. doi:10.1186/s13063-019-3971-6. ISSN 1745-6215. PMID 31941539. PMC 6961395. https://doi.org/10.1186/s13063-019-3971-6. 
  14. Adam, Rosalind; McMichael, Drew; Powell, Daniel; Murchie, Peter (2019). "Publicly available apps for cancer survivors: a scoping review" (in en). BMJ Open 9 (9): e032510. doi:10.1136/bmjopen-2019-032510. ISSN 2044-6055. PMID 31575584. PMC 6773350. http://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2019-032510. 
  15. Cruz, Flávia Oliveira Almeida Marques; Vilela, Ricardo Alencar; Ferreira, Elaine Barros; Melo, Nilce Santos; Reis, Paula Elaine Diniz Dos (2019-08-27). "Evidence on the Use of Mobile Apps During the Treatment of Breast Cancer: Systematic Review" (in en). JMIR mHealth and uHealth 7 (8): e13245. doi:10.2196/13245. ISSN 2291-5222. PMID 31456578. PMC 6734853. http://mhealth.jmir.org/2019/8/e13245/. 
  16. Young-Afat, Danny A.; Gils, Carla H. van; Bruinvels, David J.; Pol, Carmen C. van der; Witkamp, Arjen J.; Sijtsema, Sieta; Jonasse, Yvette; Bijlsma, Rhodé M. et al. (2016). "Patients’ and Health Care Providers’ Opinions on a Supportive Health App During Breast Cancer Treatment: A Qualitative Evaluation" (in en). JMIR Cancer 2 (1): e8. doi:10.2196/cancer.5334. https://cancer.jmir.org/2016/1/e8/. 
  17. "OWise selected for phase two of Cancer Innovation Challenge". February 19, 2018. https://nhsaccelerator.com/owise-selected-phase-two-cancer-innovation-challenge/. 
  18. Bruinvels, Anne (September 28, 2018). "Patients helping to drive innovation in NHS Scotland". https://cancerchallengescotland.com/blog/patients-helping-drive-innovation-nhs-scotland. 
  19. "Healthier Lives Data Fund prize". March 2020. https://www.nesta.org.uk/press-release/healthier-lives-data-fund-prize/. 

Script error: No such module "AFC submission catcheck".